Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119188912 | 11918891 | 2 | F | 200410 | 20160720 | 20160115 | 20160907 | PER | US-JNJFOC-20151205111 | JANSSEN | 47.18 | YR | A | M | Y | 80.74000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119188912 | 11918891 | 1 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | FOR 13 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 2 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 28 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | FOR 28 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 4 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 28 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 5 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | FOR 13 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 6 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | FOR 28 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 7 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | FOR 13 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 8 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | FOR 28 DAYS | U | U | 0 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 9 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 28 DAYS | U | U | 20634 | 500 | MG | UNSPECIFIED | |||||
| 119188912 | 11918891 | 10 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | U | 0 | 500 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119188912 | 11918891 | 1 | Prostatitis |
| 119188912 | 11918891 | 2 | Prostatitis |
| 119188912 | 11918891 | 3 | Prostatitis |
| 119188912 | 11918891 | 4 | Urosepsis |
| 119188912 | 11918891 | 5 | Urosepsis |
| 119188912 | 11918891 | 6 | Urosepsis |
| 119188912 | 11918891 | 7 | Urinary tract infection |
| 119188912 | 11918891 | 8 | Urinary tract infection |
| 119188912 | 11918891 | 9 | Urinary tract infection |
| 119188912 | 11918891 | 10 | Urosepsis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119188912 | 11918891 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119188912 | 11918891 | Mental disorder | |
| 119188912 | 11918891 | Musculoskeletal pain | |
| 119188912 | 11918891 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119188912 | 11918891 | 1 | 20040930 | 2004 | 0 | |
| 119188912 | 11918891 | 2 | 20041021 | 2004 | 0 | |
| 119188912 | 11918891 | 3 | 20041101 | 2004 | 0 | |
| 119188912 | 11918891 | 4 | 20041021 | 2004 | 0 | |
| 119188912 | 11918891 | 5 | 20040930 | 2004 | 0 | |
| 119188912 | 11918891 | 6 | 20041101 | 2004 | 0 | |
| 119188912 | 11918891 | 7 | 20040930 | 2004 | 0 | |
| 119188912 | 11918891 | 8 | 20041101 | 2004 | 0 | |
| 119188912 | 11918891 | 9 | 20041021 | 2004 | 0 | |
| 119188912 | 11918891 | 10 | 20041227 | 20041231 | 0 |